(Q44117848)

30 November 2017

title

Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells (English)

1 reference

30 November 2017

S Le Gouill

1

1 reference

30 November 2017

C Pellat-Deceunynck

2

1 reference

30 November 2017

J-L Harousseau

3

1 reference

30 November 2017

M-J Rapp

4

1 reference

30 November 2017

N Robillard

5

1 reference

30 November 2017

R Bataille

6

1 reference

30 November 2017

M Amiot

7

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

16

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1664-1667

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402629

30 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Farnesyltransferase inhibitor induces rapid growth arrest and blocks p70s6k activation by multiple stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402629

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402629

1 reference

30 November 2017

1 reference